Hesselmar et al. [19], 2002
|
Sweden
|
Case–control
|
950
|
15–25y
|
Questionnaire
|
SGA
|
–
|
Grischkan et al. [21], 2004
|
American
|
Cohort
|
251
|
8–11y
|
Questionnaire
|
SGA
|
24–36w
|
Jaakkola and Gissler [16], 2004
|
Finland
|
Cohort
|
58,841
|
0–7y
|
Medical record
|
SGA
|
–
|
Gessner and Chimonas [12], 2007
|
American
|
Cross-sectional
|
37,349
|
< 10y
|
Medical record
|
SGA
|
–
|
Lu et al. [18], 2012
|
Taiwan
|
Cross-sectional
|
75,181
|
10–17y
|
Medical record and Questionnaire
|
SGA; AGA; LGA
|
–
|
Wang et al. [20], 2012
|
Taiwan
|
Cross-sectional
|
78,011
|
13–16y
|
Questionnaire
|
SGA
|
–
|
Kalen et al. [14], 2013
|
Sweden
|
Cross-sectional
|
763,666
|
2–11y
|
Medical record
|
SGA; AGA; LGA
|
23–44w
|
Koshy et al. [24], 2013
|
UK
|
Cross-sectional
|
6361
|
5–11y
|
Questionnaire
|
SGA
|
39–41w
|
Miyake and Tanaka [15], 2013
|
Japanese
|
Cross-sectional
|
2004
|
3y
|
Questionnaire
|
SGA
|
–
|
Liu et al. [22], 2014
|
Sweden Finland Denmark
|
Cohort
|
5,656,507
|
3–18y
|
Medical record
|
SGA; LGA; AGA
|
22–45w
|
Pinto et al. [23], 2017
|
Netherlands
|
Cohort
|
1608
|
8y
|
Questionnaire
|
LGA
|
38–42w
|
Carter et al. [13], 2019
|
Canada
|
Cohort
|
32,867
|
0–25y
|
Medical record
|
SGA; LGA; AGA
|
≥ 37w
|